Australia markets closed

Poolbeg Pharma PLC (7JN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1370-0.0030 (-2.14%)
At close: 08:06AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Total revenue
0
0
0
Cost of revenue
0
0
0
Gross profit
0
0
0
Operating expenses
Research development
2,412
2,204
414
Selling general and administrative
3,227
3,060
2,031
Total operating expenses
5,317
4,986
2,336
Operating income or loss
-5,317
-4,986
-2,336
Income before tax
-4,881
-4,777
-2,336
Income tax expense
9
-91
0
Income from continuing operations
-4,890
-4,686
-2,336
Net income
-4,890
-4,686
-2,336
Net income available to common shareholders
-4,890
-4,686
-2,336
Basic EPS
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
Basic average shares
500,000
500,000
317,227
Diluted average shares
500,000
500,000
317,227